Study Results from Inova Schar Cancer Institute Provide New Insights into Breast Cancer (Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer)

Press/Media

Period27 Sep 2024

Media coverage

1

Media coverage

  • TitleStudy Results from Inova Schar Cancer Institute Provide New Insights into Breast Cancer (Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancer)
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date27/09/24
    PersonsThomas Conrads
View all 1
View less

Related content